TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 2 | 1 | 4 | 18 | 45 | 14 | -8 | 12 |
P | %wins | 100 | 100 | 100 | 50 | 50 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/24/16 16:29 | 8/23/16 | JNP | Juniper Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Armstrong Frank M | MA | D | P | 10 | 6.16 | 0 | 2 | 9 | 20 | D | 1 | -36 | -18 | -13 | -20 | -17 | -14 | 5 | 1 | 0 | 8 | -1 | -14 | ||
6/16/15 13:15 | 6/15/15 | JNP | Juniper Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Armstrong Frank M | MA | D | P | 10 | 7.95 | 0 | 1 | 32 | 5 | D | 49 | 18 | 39 | -4 | 10 | 5 | 6 | 3 | 1 | 7 | 28 | 90 | 41 | -8 | |
5/2/08 10:43 | 5/1/08 | CRGN | Curagen Corp | DE | Health | Biolab | Commercial Physical & Biologi | Armstrong Frank M | CT | D | S | -32 | 0.9051 | 0 | -35 | -9 | 375 | D | |||||||||||||||
2/12/08 14:07 | 2/11/08 | CRGN | Curagen Corp | DE | Health | Biolab | Commercial Physical & Biologi | Armstrong Frank M | CT | D | S | -17 | 0.7329 | 0 | -23 | -5 | 410 | D | |||||||||||||||
8/14/07 15:27 | 8/10/07 | CRGN | Curagen Corp | DE | Health | Biolab | Commercial Physical & Biologi | Armstrong Frank M | CT | DO | CEO | P | 5 | 1.33 | 0 | 3 | 1 | 633 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |